Fidson Healthcare

Fidson Healthcare Interest Coverage

The Interest Coverage Ratio of Fidson Healthcare (FIDSON.NL) as of Oct 31, 2026 is 1.71. In the previous year, Interest Coverage Ratio was 2.77 — a change of -38.34% (lower).

Interest Coverage

1.71

YoY

-38.34%

Last updated:

Interest Coverage Ratio of Fidson Healthcare is 2024 1.71 . Interest Coverage Ratio of Fidson Healthcare was 2023 2.77 . It decreases by -38.34% lower compared to the previous year.

The Fidson Healthcare Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
2.62 NGN
Jan 1, 2018
1.09 NGN
Jan 1, 2019
1.34 NGN
Jan 1, 2020
2.33 NGN
Jan 1, 2021
2.35 NGN
Jan 1, 2022
3.33 NGN
Jan 1, 2023
2.77 NGN
Jan 1, 2024
1.71 NGN
The Fidson Healthcare Interest Coverage history
YEARInterest CoverageYoY
1.71-38.34%
2.77-16.85%
3.33+41.48%
2.35+0.99%
2.33+73.93%
1.34+23.48%
1.09-58.65%
2.62+55.74%
1.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fidson Healthcare Stock analysis

What does Fidson Healthcare do? Fidson Healthcare Plc manufactures and distributes pharmaceutical products, including drugs, infusion and injectables, across its segments: over-the-counter, ethical products, and consumer. The over-the-counter segment sells products directly to consumers without prescriptions, while the ethical products segment offers prescription-only drugs, injectables, and infusions. The consumer segment focuses on household items. The company provides formulation/development, contract manufacturing, and production services for medicines. Its product portfolio includes Anti Infective & Anti Malaria, Central Nervous System (CNS), Gastrointestinal Medicines, Supplements, Topical/Dermatological Medicines, Vitamins & Minerals, Ophthalmic Solution, and others, with Ophthalmic Solution specifically targeting eye conditions. The company's primary revenue streams come from the sale of pharmaceutical products within its three segments. Over-the-counter products are purchased by general consumers, ethical products are bought by healthcare providers and pharmacies requiring prescriptions, and consumer segment items are sold to households. Fidson Healthcare Plc serves the Nigerian market through its manufacturing and distribution network, leveraging its full-time workforce of 593 employees to support operations. Fidson Healthcare Plc's product lines are tailored to specific market needs, with Anti Infective & Anti Malaria products addressing infectious diseases, CNS medications targeting neurological disorders, and Ophthalmic Solution treating eye conditions. The company's services in formulation/development and contract manufacturing further generate revenue by supporting other pharmaceutical firms in product creation and production. Fidson Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fidson Healthcare stock

Interest Coverage Ratio of Fidson Healthcare is 1.71 in 2024.

Interest Coverage Ratio of Fidson Healthcare changed from 2.77 to 1.71, representing a -38.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Fidson Healthcare since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Fidson Healthcare with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Fidson Healthcare

All Key Metrics — Fidson Healthcare